NanoMosaic Announces Its Second Commercial Sale of the World's First Proteomics/Multi-Omics System,



- Feb 2, 2022
- 2 min
NanoMosaic Announces its "Proteomics/Multi-Omics Early Access Program" and its First System Sale to

- Jan 24, 2022
- 2 min
NanoMosaic Signs 31K Square Foot Lease and Establishes "Multi-Omics World Headquarters" in Waltham,

- Dec 6, 2021
- 3 min
NanoMosaic Closes a $40.75MM Over-Subscribed Series A Round

- Oct 20, 2021
- 3 min
NanoMosaic Demonstrates Robust Aptamer Performance for Protein Quantitation on the Company's Tessie™


- Apr 13, 2021
- 3 min
NanoMosaic Unveils Full Proteome Wide Association Study (PWAS) Marker Set Development at 2021 AACR

- Apr 6, 2021
- 3 min
NanoMosaic Installs Wide Dynamic Range Proteomic Beta System at The NYSCF

- Dec 16, 2020
- 1 min
NanoMosaic Tessie To Run Clinical Samples At Massachusetts General Hospital Beta Placement


- Oct 28, 2020
- 1 min
NanoMosaic Ships First Beta System To A Prestigious Institution

- Oct 14, 2020
- 1 min
Protein Detection Pioneer, NanoMosaic, Prepares to Ship Its Powerful New Beta Platform in the Battle


- Oct 7, 2020
- 1 min
NanoMosaic In The News:
- Jul 1, 2020
- 2 min
2020 AACR: NanoMosaic Unveils Ultra-sensitive Quantitative Platform
- Apr 6, 2020
- 2 min
NanoMosaic announces collaboration with Massachusetts General Hospital to Develop Test for COVID-19
- Apr 2, 2020
- 2 min
NanoMosaic Announces Exclusive License to Nanoneedle Technology from Harvard